Trump’s executive order to cap U.S. costs risks limiting the supply of new pharmaceuticals. President Donald Trump’s ...

Economists begin by asking what would happen in a completely free market. Then we ask whether government intervention of some ...

While Trump has not yet turned to price controls to address America‘s absurdly high drug prices, Monday‘s executive order ...

Experts said Trump’s action could lower the cost of prescription drugs, but they cautioned it's far from an immediate fix.

Experts said the president's executive order could work in lowering costs, but it won't make for an immediate fix.

SaveHealth explores the distinctions between brand-name and generic drugs, outlines the financial advantages of generic ...

Under the Medicare Drug Price Negotiation Program, the HHS secretary negotiates directly with manufacturers on the prices ...

A study by the Rand Corp., a nonpartisan research organization, found that, across all drugs, U.S. prices were 2.78 times as ...

Remarkably many of the drugs, including pembrolizumab, were not available throughout much of that period – yet ... did not factor in the cost of research and development, but Global Justice ...

In the face of such pressure, pharmaceutical companies are eager to reduce the cost of drug development so that ... and more accurate clinical trial periods. More data and faster analysis mean ...

A new study finds that CivicaScript, a not-for-profit drug manufacturer in the US, can reliably supply essential generic ...

Cash expected to fund operations into the second half of 2026Advancing development strategy for lead program TPI 287 to commence Phase 2 study around year end 2025 for treatment of glioblastoma ...